Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010090
Filing Date
2020-08-10
Accepted
2020-08-10 11:22:43
Documents
86
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vstm-20200630x10q.htm   iXBRL 10-Q 1695506
2 EX-31.1 vstm-20200630xex31d1.htm EX-31.1 13273
3 EX-31.2 vstm-20200630xex31d2.htm EX-31.2 13646
4 EX-32.1 vstm-20200630xex32d1.htm EX-32.1 7925
5 EX-32.2 vstm-20200630xex32d2.htm EX-32.2 8019
  Complete submission text file 0001558370-20-010090.txt   8111125

Data Files

Seq Description Document Type Size
6 EX-101.SCH vstm-20200630.xsd EX-101.SCH 64679
7 EX-101.CAL vstm-20200630_cal.xml EX-101.CAL 63632
8 EX-101.DEF vstm-20200630_def.xml EX-101.DEF 259855
9 EX-101.LAB vstm-20200630_lab.xml EX-101.LAB 603969
10 EX-101.PRE vstm-20200630_pre.xml EX-101.PRE 443824
11 EXTRACTED XBRL INSTANCE DOCUMENT vstm-20200630x10q_htm.xml XML 1450735
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 201087985
SIC: 2834 Pharmaceutical Preparations